 CAMBRIDGE, Mass., March 08, 2022 GLOBE NEWSWIRE -- Checkmate Pharmaceuticals, Inc. NASDAQ: CMPI Checkmate, a clinical stage biotechnology company focused on developing its proprietary technology to harness the power of the immune system to combat cancer, today announced that it will present biomarker data at the 2022 American Association for Cancer Research AACR Annual Meeting taking place in New Orleans, Louisiana from April 8-13, 2022. An e-poster will be made available online starting Friday, April 8 at 1:00pm ET. 